They used videos of infants undergoing painful procedures to ascertain if Painchek picked up the pain, this forms a baseline, then compared to the normal pain charts and found a excellent co-relation, i.e. we know the child is in pain, paincheck picks up the correct level of pain...... i.e. paincheck works on infants.
This means we will be able to continue to build out the infant Paincheck app etc......(p.s. this is big but don't tell anyone. every parent in the world wants this app...)
See below
Using the face only automatic assessment, PainChek Infant demonstrated effectiveness in procedural pain
assessment, with comparison against the NFCS-R and ObsVAS demonstrating the psychometric properties of the
technology i.e. validity, reliability and internal consistency. The findings showed that PainChek Infant (Face Only) has
excellent correlation with NFCS-R and ObsVAS, and detailed results of the study will be made available following the
peer-review and publication in a scientific journal.
- Forums
- ASX - By Stock
- PCK
- Ann: Successful Completion of Infant Face-Only Clinical Study
Ann: Successful Completion of Infant Face-Only Clinical Study, page-6
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PCK (ASX) to my watchlist
|
|||||
Last
3.3¢ |
Change
-0.003(8.33%) |
Mkt cap ! $53.98M |
Open | High | Low | Value | Volume |
3.6¢ | 3.6¢ | 3.3¢ | $91.67K | 2.719M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 187734 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.6¢ | 885331 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 356734 | 0.033 |
4 | 587746 | 0.032 |
4 | 522340 | 0.031 |
5 | 922000 | 0.030 |
2 | 520000 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 100000 | 1 |
0.036 | 885331 | 1 |
0.037 | 125000 | 1 |
0.038 | 29998 | 1 |
0.040 | 50000 | 1 |
Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |